Mythic Therapeutics

0 followers


Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.

Industries

Headquarters

Stage

Employees

Links

Org chart

Sandra Poole
Chief Operating Officer
Nick Mathisen
VP, Head of Information Technology